Literature DB >> 1821204

A new autosomal dominant vascular retinopathy syndrome.

C W Storimans1, M J Van Schooneveld, J A Oosterhuis, P J Bos.   

Abstract

We describe a new syndrome with autosomal dominant transmission whose most striking feature is vascular retinopathy. The retinopathy is often associated with migraine, Raynaud's phenomenon and mental changes, mainly forgetfulness, aggression and depression. To define this syndrome we collected medical data on 110 family members. General ophthalmological examination and fluorescein angiography were performed in 61 persons. The retinopathy, as diagnosed in 22 persons, is characterized by central and peripheral microangiopathy, areas of capillary non-perfusion, haemorrhages, cotton wool spots and, in a more advanced stage, occlusion of large retinal vessels, which can induce a neovascular response. A vascular occlusive disorder may be the common aetiological factor of the various manifestation of this syndrome.

Entities:  

Mesh:

Year:  1991        PMID: 1821204     DOI: 10.1177/112067219100100204

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  8 in total

1.  A 44-year-old man with eye, kidney, and brain dysfunction.

Authors:  Ivana Vodopivec; Derek H Oakley; Cory A Perugino; Nagagopal Venna; E Tessa Hedley-Whyte; John H Stone
Journal:  Ann Neurol       Date:  2016-03-07       Impact factor: 10.422

Review 2.  Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures.

Authors:  Niall Patton; Tariq Aslam; Thomas Macgillivray; Alison Pattie; Ian J Deary; Baljean Dhillon
Journal:  J Anat       Date:  2005-04       Impact factor: 2.610

3.  Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3.

Authors:  R A Ophoff; J DeYoung; S K Service; M Joosse; N A Caffo; L A Sandkuijl; G M Terwindt; J Haan; A M van den Maagdenberg; J Jen; R W Baloh; M L Barilla-LaBarca; N L Saccone; J P Atkinson; M D Ferrari; N B Freimer; R R Frants
Journal:  Am J Hum Genet       Date:  2001-06-28       Impact factor: 11.025

4.  Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations.

Authors:  Anine H Stam; Parul H Kothari; Aisha Shaikh; Andreas Gschwendter; Joanna C Jen; Suzanne Hodgkinson; Todd A Hardy; Michael Hayes; Peter A Kempster; Katya E Kotschet; Ingeborg M Bajema; Sjoerd G van Duinen; Marion L C Maat-Schieman; Paulus T V M de Jong; Marc D de Smet; Didi de Wolff-Rouendaal; Greet Dijkman; Nadine Pelzer; Grant R Kolar; Robert E Schmidt; JoAnne Lacey; Daniel Joseph; David R Fintak; M Gilbert Grand; Elizabeth M Brunt; Helen Liapis; Rula A Hajj-Ali; Mark C Kruit; Mark A van Buchem; Martin Dichgans; Rune R Frants; Arn M J M van den Maagdenberg; Joost Haan; Robert W Baloh; John P Atkinson; Gisela M Terwindt; Michel D Ferrari
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

5.  Migraine genetics: current findings and future lines of research.

Authors:  A M Persico; M Verdecchia; V Pinzone; V Guidetti
Journal:  Neurogenetics       Date:  2014-12-14       Impact factor: 2.660

6.  Serotoninergic status in patients with hereditary vascular retinopathy syndrome.

Authors:  C W Storimans; D Fekkes; A van Dalen; E D Bleeker-Wagemakers; J A Oosterhuis
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

7.  TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy.

Authors:  Jacopo C DiFrancesco; Francesca Novara; Orsetta Zuffardi; Antonella Forlino; Roberta Gioia; Federica Cossu; Martino Bolognesi; Simona Andreoni; Enrico Saracchi; Barbara Frigeni; Tiziana Stellato; Markus Tolnay; David T Winkler; Paolo Remida; Giuseppe Isimbaldi; Carlo Ferrarese
Journal:  Neurol Sci       Date:  2014-09-12       Impact factor: 3.307

8.  Hereditary systemic angiopathy (HSA) with cerebral calcifications, retinopathy, progressive nephropathy, and hepatopathy.

Authors:  D T Winkler; P Lyrer; A Probst; D Devys; T Haufschild; S Haller; N Willi; M J Mihatsch; A J Steck; M Tolnay
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 6.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.